W.P. Burkard

2.9k total citations
63 papers, 2.3k citations indexed

About

W.P. Burkard is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biochemistry. According to data from OpenAlex, W.P. Burkard has authored 63 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 25 papers in Cellular and Molecular Neuroscience and 10 papers in Biochemistry. Recurrent topics in W.P. Burkard's work include Neurotransmitter Receptor Influence on Behavior (15 papers), Neuroscience and Neuropharmacology Research (13 papers) and Receptor Mechanisms and Signaling (8 papers). W.P. Burkard is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (15 papers), Neuroscience and Neuropharmacology Research (13 papers) and Receptor Mechanisms and Signaling (8 papers). W.P. Burkard collaborates with scholars based in Switzerland, Germany and United States. W.P. Burkard's co-authors include A. Pletscher, K.F. Gey, W. Haefely, M. Da Prada, H. H. Keller, G. Bartholini, R. Kettler, L. Pieri, M Jalfre and H. Bruderer and has published in prestigious journals such as Nature, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

W.P. Burkard

61 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.P. Burkard Switzerland 27 1.2k 826 351 309 265 63 2.3k
Donald F. Bogdanski United States 24 1.4k 1.1× 1.1k 1.3× 270 0.8× 385 1.2× 202 0.8× 34 2.8k
Philippe Protais France 28 1.4k 1.1× 946 1.1× 202 0.6× 238 0.8× 207 0.8× 63 2.3k
Albert Weissman United States 18 1.6k 1.3× 791 1.0× 405 1.2× 378 1.2× 118 0.4× 53 2.8k
A. A. Boulton Canada 32 1.6k 1.3× 1.2k 1.5× 342 1.0× 349 1.1× 473 1.8× 100 3.0k
Nicholas J. Giarman United States 28 1.2k 1.0× 875 1.1× 239 0.7× 441 1.4× 117 0.4× 68 2.4k
H. H. Keller Switzerland 21 1.1k 0.9× 594 0.7× 215 0.6× 235 0.8× 276 1.0× 35 2.0k
M. Da Prada Switzerland 25 884 0.7× 735 0.9× 229 0.7× 242 0.8× 457 1.7× 50 2.3k
Michael G. Palfreyman France 32 1.8k 1.4× 1.3k 1.6× 362 1.0× 291 0.9× 290 1.1× 99 3.3k
Harold D. Snoddy United States 25 1.1k 0.9× 594 0.7× 298 0.8× 312 1.0× 103 0.4× 82 2.0k
A. Horita United States 32 1.3k 1.0× 739 0.9× 189 0.5× 475 1.5× 128 0.5× 119 2.6k

Countries citing papers authored by W.P. Burkard

Since Specialization
Citations

This map shows the geographic impact of W.P. Burkard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.P. Burkard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.P. Burkard more than expected).

Fields of papers citing papers by W.P. Burkard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.P. Burkard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.P. Burkard. The network helps show where W.P. Burkard may publish in the future.

Co-authorship network of co-authors of W.P. Burkard

This figure shows the co-authorship network connecting the top 25 collaborators of W.P. Burkard. A scholar is included among the top collaborators of W.P. Burkard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.P. Burkard. W.P. Burkard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simmen, Urs, W.P. Burkard, Karin Berger, W. Schaffner, & Kenneth Lundström. (1999). Extracts and Constituents ofHypericum PerforatumInhibit the Binding of Various Ligands to Recombinant Receptors Expressed with the Semliki Forest Virus System. Journal of Receptors and Signal Transduction. 19(1-4). 59–74. 50 indexed citations
2.
Haefely, W., W.P. Burkard, Andrea M. Cesura, et al.. (1993). Pharmacology of moclobemide.. PubMed. 16 Suppl 2. S8–18. 32 indexed citations
3.
Haefely, W., W.P. Burkard, Andrea M. Cesura, et al.. (1992). Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology. 106(S1). S6–S14. 85 indexed citations
4.
Burkard, W.P., Francesco D’Agostini, R. Kettler, & M. Da Prada. (1992). Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats. Psychopharmacology. 106(S1). S35–S36. 3 indexed citations
5.
Imhof, R., et al.. (1992). New insight into structural and stereochemical requirements for selective, high affinity ligands at the dopamine D2 receptor. Neurochemistry International. 20. 75–80. 3 indexed citations
6.
Kettler, R., M. Da Prada, & W.P. Burkard. (1990). Comparison of monoamine oxidase‐A inhibition by moclobemide in vitro and ex vivo in rats. Acta Psychiatrica Scandinavica. 82(S360). 101–102. 37 indexed citations
7.
Prada, M. Da, R. Kettler, H. H. Keller, & W.P. Burkard. (1990). Short‐lasting and reversible inhibition of monoamine oxidase‐A by moclobemide. Acta Psychiatrica Scandinavica. 82(S360). 103–105. 11 indexed citations
8.
Notter, Michael, et al.. (1989). [Hyperthermia--a new element in cancer treatment].. PubMed. 78(34). 897–904. 1 indexed citations
9.
Kettler, R., et al.. (1984). Minimal potentiation of pressor response to oral tyramine in rats given moclobemide alone or combined with sodium uptake inhibitors. 36. 41. 1 indexed citations
10.
Heckers, H., W.P. Burkard, F. W. Schmahl, Walter Fuhrmann, & D. Platt. (1982). Hyper-Alpha-Lipoproteinemia and Hypo-Beta-Lipoproteinemia Are Not Markers for a High Life Expectancy. Gerontology. 28(3). 176–202. 10 indexed citations
11.
Prada, M. Da, A. Saner, W.P. Burkard, G. Bartholini, & A. Pletscher. (1975). Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors. Brain Research. 94(1). 67–73. 52 indexed citations
12.
Burkard, W.P.. (1975). Adenylate cyclase in the central nervous system. Progress in Neurobiology. 4. 241–267. 8 indexed citations
13.
Burkard, W.P., et al.. (1972). Blockade of central 5-hydroxytryptamine receptors by methiothepin. Naunyn-Schmiedeberg s Archives of Pharmacology. 274(2). 192–197. 108 indexed citations
14.
Burkard, W.P., K.F. Gey, H. Weiser, & Ulrich Schwieter. (1968). Decrease of norepinephrine in brain and heart of vitamin E deficient rats. Cellular and Molecular Life Sciences. 24(8). 807–808. 6 indexed citations
15.
Bartholini, G., et al.. (1967). Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase. Nature. 215(5103). 852–853. 206 indexed citations
16.
Gey, K.F., W.P. Burkard, & A. Pletscher. (1965). Variation of the Norepinephrine Metabolism of the Rat Heart with Age. Gerontology. 11(1-2). 1–11. 53 indexed citations
17.
Gey, K.F., A. Pletscher, & W.P. Burkard. (1963). EFFECT OF INHIBITORS OF MONOAMINE OXIDASE ON VARIOUS ENZYMES AND ON THE STORAGE OF MONOAMINES. Annals of the New York Academy of Sciences. 107(3). 1147–1151. 23 indexed citations
18.
Burkard, W.P., K.F. Gey, & A. Pletscher. (1962). A new inhibitor of decarboxylase of aromatic amino acids. Cellular and Molecular Life Sciences. 18(9). 411–412. 55 indexed citations
19.
Burkard, W.P. & R. Keller. (1956). [Effects of heparin on histamine induced contraction of guinea pig ileum].. PubMed. 12(10). 394–394. 2 indexed citations
20.
Burkard, W.P., Yoram Cohen, & G Valette. (1956). [Distribution of histaminase in different organs of certain animals].. PubMed. 31(7/8). 382–90. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald F. Bogdanski Breakdown of academic impact, for papers by Philippe Protais Breakdown of academic impact, for papers by Albert Weissman Breakdown of academic impact, for papers by A. A. Boulton Breakdown of academic impact, for papers by Nicholas J. Giarman Breakdown of academic impact, for papers by H. H. Keller Breakdown of academic impact, for papers by M. Da Prada Breakdown of academic impact, for papers by Michael G. Palfreyman Breakdown of academic impact, for papers by Harold D. Snoddy Breakdown of academic impact, for papers by A. Horita
Rankless by CCL
2026